Hillevax inc
WebAbout HilleVax, Inc. 75 STATE STREET SUITE 100 - 9995, BOSTON, Massachusetts, 2109, United States +1 617 213-5054. HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on ... WebApr 6, 2024 · The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2024. HilleVax, Inc. was founded in 2024 and is headquartered in Boston, Massachusetts.
Hillevax inc
Did you know?
WebNov 10, 2024 · --HilleVax, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the quarter ended September 30, 2024 ... WebApr 29, 2024 · HilleVax, Inc. April 28, 2024, 9:03 PM · 2 min read J.P. Morgan, SVB Securities, Stifel and Guggenheim Securities are acting as joint book-running managers for the offering.
WebCompany Type For Profit. Contact Email [email protected]. Phone Number (617) 213-5054. HilleVax is a biopharmaceutical company that focuses on the development and … WebShe is currently the Head of Clinical Serology at HilleVax, Inc, a biopharmaceutical company focused on the development and commercialization of a vaccine candidate for Norovirus. Shannon has ...
WebDec 31, 2024 · HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress. HLVX 3 days ago. BOSTON, March 17, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the … WebHilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle …
WebSep 8, 2024 · BOSTON--(BUSINESS WIRE)--HilleVax, Inc. (HilleVax), a biopharmaceutical company focused on the development and commercialization of novel vaccine …
WebJul 29, 2024 · For HilleVax, Inc.: David Socks [email protected] +1-650-325-5156 For Frazier Healthcare Partners: Liz Park [email protected] +1-650-319-1831 … tsfh impossibleWebHilleVax, Inc. Document Metadata. Filed: March 17th, 2024. Contract Type Stock Restriction Agreement; Country United States; Jurisdiction California; Industry Biological products, … phil of the future 102WebNorovirus is responsible for greater than 90% of epidemic non-bacterial outbreaks of gastroenteritis. [1, 2] 700 M+. Norovirus is estimated to cause approximately 700 million cases of gastroenteritis and 200,000 deaths worldwide annually. [3] $ 60 B+. The global economic burden of norovirus is estimated to be $60.3 billion annually. tsfh invincibleWebSep 8, 2024 · Norovirus vaccine . Less than two months after spinning out of Takeda Pharmaceuticals, HilleVax, Inc. secured $135 million in crossover financing to advance the development of its Phase III-ready norovirus vaccine.. The funds will be used to support further clinical development of its virus-like particle (VLP) based vaccine candidate, HIL … tsfh for the winWebNovartis Vaccines. Nov 2009 - Oct 20112 years. On international assignment in Germany, managed a department of over 50 people which incorporated Sterility Assurance oversight for the site into the ... tsf histoireWebHilleVax, Inc. Document Metadata. Filed: March 17th, 2024. Contract Type Stock Restriction Agreement; Country United States; Jurisdiction California; Industry Biological products, (no disgnostic substances) Company HilleVax, Inc. SEC Filing ID 0000950170-23-008647; SEC Filing Type 10-k; SEC Exhibit ID ex-10; tsfhlWebAbout. Experienced leader in the CRO/Clinical Trials field. Currently the Head of the Sample Management function for a vaccines biopharmaceutical … phil of the future brenda song